2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

IMPACT Therapeutics Funding History

Since IMPACT Therapeutics was founded in 2009, it has participated in 5 rounds of funding. In total IMPACT Therapeutics has raised $129.7M. IMPACT Therapeutics' last funding round was on Nov 2024 for a total of $34.5M.

IMPACT Therapeutics Funding Rounds

Unlock 2 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series D
Nov 2024
$34.5M
__
Series D
Apr 2024
$55.2M
__
Series D
Mar 2022
--
4
Dingxin Capital,  Exome Asset Management LLC,  Lilly Asia Ventures,  YUEXIU FINANCIAL HOLDINGS GROUP CO.LTD.
Series C
Aug 2018
$30M
2
Decheng Capital, LLC,  Lilly Asia Ventures
Series B
Feb 2016
$10M
3
Guangzhou Yuexiu Industrial Investment Fund,  Lilly Asia Ventures,  Hangzhou Hai Bang Investment Management Ltd

Total Funding: $129.7M

IMPACT Therapeutics Investors

Unlock 4 more investors →

INVESTOR

ROUND

FUNDING DATE

Dingxin Capital
Series D
Mar 2022
Exome Asset Management LLC
Series D
Mar 2022
Lilly Asia Ventures
Series D, Series C, Series B
Mar 2022, Aug 2018, Feb 2016
YUEXIU FINANCIAL HOLDINGS GROUP CO.LTD.
Series D
Mar 2022
Decheng Capital, LLC
Series C
Aug 2018

Total Investors: 7

IMPACT Therapeutics has 7 investors, including Dingxin Capital, Exome Asset Management LLC and Lilly Asia Ventures. The latest investment occurred in Nov 2024.